INHIBITEUR SÉLECTIF DE L'EGFR MUTANT PAR INSERTION DE L'EXON 20

摘要

An antitumor agent comprising a compound selected from the group consisting of Compounds A to D described in the specification, or a salt thereof, for treating a malignant tumor patient expressing EGFR having exon 20 insertion mutation.